Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Urothelial Cancer/Enfortumab Vedotin

Shilpa Gupta

MD

🏢Cleveland Clinic🌐USA

Director, GU Medical Oncology

45
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Shilpa Gupta is a leading GU oncologist advancing immunotherapy and ADC strategies for urothelial cancer at Cleveland Clinic. She has contributed to multiple enfortumab vedotin trials and leads research on upper tract urothelial carcinoma. Her work on biomarker-driven treatment selection is improving outcomes for bladder cancer patients across treatment settings.

Share:

🧪Research Fields 研究领域

Urothelial cancer
Immunotherapy
ADC therapy
Upper tract urothelial cancer
Biomarker research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Shilpa Gupta 的研究动态

Follow Shilpa Gupta's research updates

留下邮箱,当我们发布与 Shilpa Gupta(Cleveland Clinic)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment